rs1061122

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000361147.8(KCNN3):​c.-102G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.22 in 1,612,166 control chromosomes in the GnomAD database, including 42,768 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 6422 hom., cov: 33)
Exomes 𝑓: 0.21 ( 36346 hom. )

Consequence

KCNN3
ENST00000361147.8 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.39

Publications

13 publications found
Variant links:
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
KCNN3 Gene-Disease associations (from GenCC):
  • Zimmermann-Laband syndrome 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.424 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNN3NM_002249.6 linkc.933+9218G>A intron_variant Intron 1 of 7 ENST00000271915.9 NP_002240.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNN3ENST00000361147.8 linkc.-102G>A 5_prime_UTR_variant Exon 1 of 8 1 ENSP00000354764.4
KCNN3ENST00000271915.9 linkc.933+9218G>A intron_variant Intron 1 of 7 1 NM_002249.6 ENSP00000271915.3
KCNN3ENST00000358505.2 linkc.-7+8135G>A intron_variant Intron 1 of 7 1 ENSP00000351295.2
KCNN3ENST00000618040.4 linkc.933+9218G>A intron_variant Intron 1 of 8 5 ENSP00000481848.1

Frequencies

GnomAD3 genomes
AF:
0.268
AC:
40720
AN:
152052
Hom.:
6418
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.430
Gnomad AMI
AF:
0.364
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.267
Gnomad EAS
AF:
0.00923
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.198
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.227
Gnomad OTH
AF:
0.241
GnomAD4 exome
AF:
0.214
AC:
313144
AN:
1459996
Hom.:
36346
Cov.:
32
AF XY:
0.212
AC XY:
153926
AN XY:
726312
show subpopulations
African (AFR)
AF:
0.436
AC:
14593
AN:
33446
American (AMR)
AF:
0.136
AC:
6042
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.254
AC:
6618
AN:
26102
East Asian (EAS)
AF:
0.00552
AC:
219
AN:
39674
South Asian (SAS)
AF:
0.132
AC:
11376
AN:
86130
European-Finnish (FIN)
AF:
0.198
AC:
10513
AN:
53178
Middle Eastern (MID)
AF:
0.241
AC:
1387
AN:
5754
European-Non Finnish (NFE)
AF:
0.225
AC:
249463
AN:
1110792
Other (OTH)
AF:
0.214
AC:
12933
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
12988
25976
38964
51952
64940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8390
16780
25170
33560
41950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.268
AC:
40745
AN:
152170
Hom.:
6422
Cov.:
33
AF XY:
0.259
AC XY:
19252
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.430
AC:
17816
AN:
41478
American (AMR)
AF:
0.191
AC:
2917
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
927
AN:
3470
East Asian (EAS)
AF:
0.00963
AC:
50
AN:
5190
South Asian (SAS)
AF:
0.127
AC:
614
AN:
4830
European-Finnish (FIN)
AF:
0.198
AC:
2105
AN:
10610
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.227
AC:
15415
AN:
67972
Other (OTH)
AF:
0.238
AC:
504
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1449
2897
4346
5794
7243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.238
Hom.:
19787
Bravo
AF:
0.273
Asia WGS
AF:
0.0710
AC:
251
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.012
DANN
Benign
0.65
PhyloP100
-3.4
PromoterAI
0.028
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1061122; hg19: chr1-154832290; COSMIC: COSV55215271; API